These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1045 related items for PubMed ID: 10718182

  • 21. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG, Pritchard J, Scambler P, Cowell JK.
    Oncogene; 1998 Jul 23; 17(3):395-400. PubMed ID: 9690521
    [Abstract] [Full Text] [Related]

  • 22. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N, Arbour L, Tonin P, Baruchel S, Pritchard-Jones K, Narod SA, Stratton MR.
    Oncogene; 1997 Jun 26; 14(25):3099-102. PubMed ID: 9223674
    [Abstract] [Full Text] [Related]

  • 23. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I, van Tinteren H, Bergeron C, de Kraker J, SIOP Nephroblastoma Study Committee.
    Eur J Cancer; 2007 Jan 26; 43(1):131-6. PubMed ID: 17084075
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM.
    J Clin Oncol; 2006 May 20; 24(15):2352-8. PubMed ID: 16710034
    [Abstract] [Full Text] [Related]

  • 28. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG, Gu WZ, Zhou YB, Tang HF, Li MJ, Ma WX.
    Eur J Clin Invest; 2008 Dec 20; 38(12):931-8. PubMed ID: 19021718
    [Abstract] [Full Text] [Related]

  • 29. [Renal neoplasms in children].
    Sawicz-Birkowska K, Czernik J, Bagłaj M, Czauderna P, Kantorowicz-Szymik S, Poznański WA, Mańkowski P, Madziara W, Prokurat A, Osemlak J.
    Przegl Lek; 2004 Dec 20; 61 Suppl 2():20-3. PubMed ID: 15686041
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
    Mathew P, Douglass EC, Jones D, Valentine M, Valentine V, Rowe S, Shapiro DN.
    Med Pediatr Oncol; 1996 Jul 20; 27(1):3-7. PubMed ID: 8614388
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J.
    Cancer Res; 1991 Nov 01; 51(21):5937-42. PubMed ID: 1657374
    [Abstract] [Full Text] [Related]

  • 35. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV, Mullen EA, Chi YY, Ehrlich PF, Perlman EJ, Kalapurakal JA, Khanna G, Paulino AC, Hamilton TE, Gow KW, Tochner Z, Hoffer FA, Withycombe JS, Shamberger RC, Kim Y, Geller JI, Anderson JR, Grundy PE, Dome JS.
    J Clin Oncol; 2018 Jan 20; 36(3):254-261. PubMed ID: 29211618
    [Abstract] [Full Text] [Related]

  • 36. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M, Devilee P, Bliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A.
    Cancer Res; 1990 Jun 01; 50(11):3279-83. PubMed ID: 2159377
    [Abstract] [Full Text] [Related]

  • 37. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J, Cowell JK.
    Oncogene; 1990 Jun 01; 5(6):901-7. PubMed ID: 2163053
    [Abstract] [Full Text] [Related]

  • 38. [Correlation of 1p/16q loss of heterozygosity and 1p gain with clinicopathological characteristics and prognosis in Wilms tumor].
    Jia C, Yao XF, Zhang M, Guan XX, Wang JW, Song HC, He LJ.
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar 08; 53(3):257-263. PubMed ID: 38433053
    [Abstract] [Full Text] [Related]

  • 39. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW, Lee HS, Chen CH, Huang GT, Lee PH, Sheu JC.
    J Gastroenterol Hepatol; 2005 Apr 08; 20(4):536-46. PubMed ID: 15836701
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.